Baudax Bio, Inc. (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0081
0.00 (0.00%)
Jul 16, 2024, 2:39 PM EDT - Market closed

Baudax Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018 2017
Market Capitalization
02192665-
Upgrade
Market Cap Growth
-30.95%-90.48%-30.04%-59.05%--
Upgrade
Enterprise Value
8531266-
Upgrade
Last Close Price
0.373.18306.881414.009688.01-
Upgrade
PE Ratio
0.00-0.02-0.85-0.25--
Upgrade
PS Ratio
1.141.3917.1753.75--
Upgrade
PB Ratio
-2.84-0.071.40-1.79-3.87-
Upgrade
P/FCF Ratio
-0.24-0.06-0.37-0.59-1.26-
Upgrade
P/OCF Ratio
-0.24-0.06-0.38-0.60-1.29-
Upgrade
EV/Sales Ratio
26.093.812.7123.35--
Upgrade
EV/EBITDA Ratio
-0.57-0.14-0.06-0.21-1.66-
Upgrade
EV/EBIT Ratio
-0.57-0.14-0.06-0.21-1.64-
Upgrade
EV/FCF Ratio
-1.38-0.17-0.06-0.26-1.28-
Upgrade
Debt / Equity Ratio
-6.76-0.330.65-0.62-0.05-
Upgrade
Debt / FCF Ratio
-0.56-0.29-0.17-0.20-0.02-
Upgrade
Asset Turnover
0.070.040.020.01--
Upgrade
Inventory Turnover
-2.800.61---
Upgrade
Quick Ratio
0.020.261.051.682.30-
Upgrade
Current Ratio
0.070.301.502.032.610.11
Upgrade
Return on Assets (ROA)
-114.93%-70.57%-53.66%-56.74%-55.85%-119.93%
Upgrade
Return on Capital (ROIC)
--819.79%-406.39%---
Upgrade
Earnings Yield
-2026.32%-3332.06%-106.63%-287.17%-50.32%-
Upgrade
FCF Yield
-1316.04%-1576.23%-266.85%-168.67%-79.38%-
Upgrade
Buyback Yield / Dilution
-2601.40%-505.82%-311.07%---
Upgrade
Total Shareholder Return
-2601.40%-505.82%-311.07%---
Upgrade
Source: S&P Capital IQ. Standard template.